Skip to main content
Journal cover image

Prolonged treatment with bevacizumab is associated with brain atrophy: a pilot study in patients with high-grade gliomas

Publication ,  Journal Article
Bag, AK; Kim, H; Gao, Y; Bolding, M; Warren, PP; Fathallah-Shaykh, HM; Gurler, D; Markert, JM; Fiveash, J; Beasley, TM; Khawaja, A; Nabors, LB ...
Published in: Journal of Neuro-Oncology
May 2015

Duke Scholars

Altmetric Attention Stats
Dimensions Citation Stats

Published In

Journal of Neuro-Oncology

DOI

EISSN

1573-7373

ISSN

0167-594X

Publication Date

May 2015

Volume

122

Issue

3

Start / End Page

585 / 593

Publisher

Springer Science and Business Media LLC

Related Subject Headings

  • Oncology & Carcinogenesis
  • 1112 Oncology and Carcinogenesis
  • 1109 Neurosciences
 

Citation

APA
Chicago
ICMJE
MLA
NLM
Bag, A. K., Kim, H., Gao, Y., Bolding, M., Warren, P. P., Fathallah-Shaykh, H. M., … Han, X. (2015). Prolonged treatment with bevacizumab is associated with brain atrophy: a pilot study in patients with high-grade gliomas. Journal of Neuro-Oncology, 122(3), 585–593. https://doi.org/10.1007/s11060-015-1751-z
Bag, Asim K., Hyunki Kim, Yi Gao, Mark Bolding, Paula P. Warren, Hassan M. Fathallah-Shaykh, Demet Gurler, et al. “Prolonged treatment with bevacizumab is associated with brain atrophy: a pilot study in patients with high-grade gliomas.” Journal of Neuro-Oncology 122, no. 3 (May 2015): 585–93. https://doi.org/10.1007/s11060-015-1751-z.
Bag AK, Kim H, Gao Y, Bolding M, Warren PP, Fathallah-Shaykh HM, et al. Prolonged treatment with bevacizumab is associated with brain atrophy: a pilot study in patients with high-grade gliomas. Journal of Neuro-Oncology. 2015 May;122(3):585–93.
Bag, Asim K., et al. “Prolonged treatment with bevacizumab is associated with brain atrophy: a pilot study in patients with high-grade gliomas.” Journal of Neuro-Oncology, vol. 122, no. 3, Springer Science and Business Media LLC, May 2015, pp. 585–93. Crossref, doi:10.1007/s11060-015-1751-z.
Bag AK, Kim H, Gao Y, Bolding M, Warren PP, Fathallah-Shaykh HM, Gurler D, Markert JM, Fiveash J, Beasley TM, Khawaja A, Friedman GK, Chapman PR, Nabors LB, Han X. Prolonged treatment with bevacizumab is associated with brain atrophy: a pilot study in patients with high-grade gliomas. Journal of Neuro-Oncology. Springer Science and Business Media LLC; 2015 May;122(3):585–593.
Journal cover image

Published In

Journal of Neuro-Oncology

DOI

EISSN

1573-7373

ISSN

0167-594X

Publication Date

May 2015

Volume

122

Issue

3

Start / End Page

585 / 593

Publisher

Springer Science and Business Media LLC

Related Subject Headings

  • Oncology & Carcinogenesis
  • 1112 Oncology and Carcinogenesis
  • 1109 Neurosciences